Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer
Pharma Tech
Big tech- and pharma-backed Iambic Therapeutics aims for $135m IPO
A US listing for the oncology specialist continues a bumper year for biotech IPOs.
Read Full Article
Pharma Tech
Roche’s Tecentriq snags FDA label expansion in type of colon cancerÂ
Tecentriq is now the first immunotherapy indicated for dMMR colon cancer specifically, which is often linked to a higher risk of progression after surgery.
Read Full Article
Pharma Tech
Bio-Techne opens GMP small molecule facility in Bristol, UK
Life science tools and diagnostics provider Bio-Techne Corporation has opened a new manufacturing facility in Bristol, UK, dedicated to GMP grade small molecules.
Read Full Article
Express Pharma
Government caps margins on cancer medicines at 30%, targets â‚ą2,500 Cr annual savings
The price control measure covers non-scheduled anti-cancer drugs and aims to reduce medicine prices by up to 70% The post Government caps margins on cancer medicines at 30%, targets â‚ą2,500 Cr annual savings appeared first on Express Pharma.
Read Full Article
Pharma Tech
Biohaven partners with Ono in $100m IgG degrader deal
Biohaven has entered into an exclusive regional collaboration and licensing agreement worth up to $100m with Ono Pharmaceutical for its MoDE pan IgG degrader portfolio.
Read Full Article
Sponsored content
Featured promotional
News
Latest stories
ET Pharma
Oct 10, 2026, 1:22 AM
Pharma lobby sues Trump administration over most favored nation pricing
The GLOBE rule intends to set hospital drug prices for Medicare patients. Its final version was published last week on exactly how a "most favored nation" pricing system based on what is paid in a group of comparable countries would be integrated in the Medicare Part B program.
Pharma Tech
Oct 9, 2026, 3:02 PM
Big tech- and pharma-backed Iambic Therapeutics aims for $135m IPO
A US listing for the oncology specialist continues a bumper year for biotech IPOs.
PharmaShots
Oct 9, 2026, 12:30 PM
Vir Biotechnology Secures the US FDA Fast Track Designation for VIR-5500 to Treat Prostate Cancer
Shots: Ref: Businesswire |  Image: Vir Biotech | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Vir Biotechnology Secures the US FDA Fast Track Designation for VIR-5500 to Treat Prostate Cancer appeared first on PharmaShots.
PharmaShots
Oct 9, 2026, 11:30 AM
BMS Reports P-III (EXCALIBER-RRMM) Trial Data on Zenbexus Combination for R/R Multiple Myeloma
Shots: Ref: Businesswire |  Image: BMS | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post BMS Reports P-III (EXCALIBER-RRMM) Trial Data on Zenbexus Combination for R/R Multiple Myeloma appeared first on PharmaShots.
Pharma Tech
Oct 9, 2026, 10:37 AM
Roche’s Tecentriq snags FDA label expansion in type of colon cancerÂ
Tecentriq is now the first immunotherapy indicated for dMMR colon cancer specifically, which is often linked to a higher risk of progression after surgery.
PharmaShots
Oct 9, 2026, 10:30 AM
The US FDA Approves Genentech’s Tecentriq Combination for Stage III dMMR Colon Cancer
Shots: Ref: Businesswire |  Image: Genentech | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post The US FDA Approves Genentech’s Tecentriq Combination for Stage III dMMR Colon Cancer appeared first on PharmaShots.
News
Latest industry coverage
Google News
Oct 10, 2026, 1:00 AM
India plans oral nanodrug to treat severe newborn jaundice - Livemint
India plans oral nanodrug to treat severe newborn jaundice  Livemint
Google News
Oct 10, 2026, 12:00 AM
China wants 5 innovative drugs with US$1b returns by 2030. Which might they be? - South China Morning Post
China wants 5 innovative drugs with US$1b returns by 2030. Which might they be?  South China Morning Post
Google News
Oct 9, 2026, 10:58 PM
Drug company gifts, meals, and payments to doctors lead to worse prescribing, review of 93 studies finds - U.S. Right to Know
Drug company gifts, meals, and payments to doctors lead to worse prescribing, review of 93 studies finds  U.S. Right to Know
Google News
Oct 9, 2026, 9:48 PM
A Look at Teva Pharmaceutical Industries Ltd (TEVA) After 4.7% G - GuruFocus
A Look at Teva Pharmaceutical Industries Ltd (TEVA) After 4.7% GÂ Â GuruFocus
Google News
Oct 9, 2026, 8:13 PM
GSK commits $800M to R&D, manufacturing hub, as Pennsylvania bonds deepen - Fierce Pharma
GSK commits $800M to R&D, manufacturing hub, as Pennsylvania bonds deepen  Fierce Pharma
Google News
Oct 9, 2026, 7:50 PM
FDA Approves Medincell’s Weltruza for Adults with Schizophrenia - Contract Pharma
FDA Approves Medincell’s Weltruza for Adults with Schizophrenia  Contract Pharma
Google News
Oct 9, 2026, 7:07 PM
Everest Medicines Appoints Two to Strengthen Global mRNA R&D Capabilities - Contract Pharma
Everest Medicines Appoints Two to Strengthen Global mRNA R&D Capabilities  Contract Pharma
Google News
Oct 9, 2026, 7:00 PM
Teva Pharmaceutical Industries Limited (TEVA) Discusses FDA Approval of Weltruza and Strategic Growth Initiatives - Slideshow (NYSE:TEVA) 2026-10-09 - Seeking Alpha
Teva Pharmaceutical Industries Limited (TEVA) Discusses FDA Approval of Weltruza and Strategic Growth Initiatives - Slideshow (NYSE:TEVA) 2026-10-09Â Â Seeking Alpha
Google News
Oct 9, 2026, 6:45 PM
Marketing tactics used by pharma companies influence physician prescribing habits - News-Medical
Marketing tactics used by pharma companies influence physician prescribing habits  News-Medical
Sponsored placement
Featured promotions
Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer